APSR2026-188

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP08-027
P82
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1208742-46904-PDF MASHKUR APSR 2026 LKH_433930.pdf
Format: PDF Only
06. Tuberculosis
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Mashkur Muhamad * Hospital Tuanku Ja'afar Respiratory Unit, Department of Internal Medicine Seremban Malaysia
Anez Aslan - Hospital Tuanku Ja'afar Respiratory Unit, Department of Internal Medicine Seremban Malaysia
Han Loong Tan - Hospital Tuanku Ja'afar Respiratory Unit, Department of Internal Medicine Seremban Malaysia
Raymund Dass Maria Dass - Hospital Tuanku Ja'afar Respiratory Unit, Department of Internal Medicine Seremban Malaysia
zamzurina abu bakar - Institut Perubatan Respiratori Respiratory Medicine Kuala Lumpur Malaysia
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Mashkur
Muhamad
mashkurmuhamad@yahoo.com
+60163384607
31-40
Malaysia
Case Report
Renal and hepatic toxicity complicating short all-oral regimen in rifampicin-resistant tuberculosis: A case of treatment failure and individualized transition.
Maximum 25 words
Abstract Content
 
 
 
 
All-oral short-course regimens are increasingly recommended for rifampicin-resistant tuberculosis (RR-TB) due to improved tolerability and avoidance of injectable agents. However, severe adverse drug reactions may necessitate treatment interruption. Evidence and standardized protocols guiding rechallenge or modification of second-line anti-tuberculosis agents, particularly in the setting of renal toxicity, remain limited.
A 54-year-old gentleman with type II diabetes mellitus and hypertension presented with a two-month history of productive cough and weight loss (60 kg to 52 kg). Chest radiograph demonstrated right lung patchy infiltrates with hilar consolidation. Sputum smear was AFB 2+, and molecular testing confirmed rifampicin-resistant Mycobacterium tuberculosis. He was commenced on a 9-month short all-oral RR-TB regimen consisting of bedaquiline, linezolid, moxifloxacin, clofazimine, pyrazinamide, ethambutol, and high-dose isoniazid, achieving sputum conversion. During treatment, he developed acute kidney injury (AKI), suspected to be linezolid-associated, with concurrent drug-induced liver injury (DILI), requiring hospitalization and treatment interruption. Linezolid was discontinued and pyrazinamide withheld. Ethionamide was rechallenged however developed DILI and AKI. The utility of kidney biopsy was considered but deemed unlikely to alter immediate management. The patient was referred to nephrology for close surveillance and monitoring. Following multidisciplinary team (MDT) discussion, the short all-oral regimen was considered treatment failure due to significant organ toxicity. He was therefore transitioned to a long individualized all-oral regimen comprising cycloserine, bedaquiline, moxifloxacin, clofazimine, and ethambutol.
RR-TB treatment may be complicated by significant renal and hepatic toxicity despite all-oral regimens. Limited standardized guidance on second-line drug rechallenge following organ injury represents an important evidence gap. Individualized MDT-based strategies with vigilant renal monitoring are essential in complex RR-TB cases.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Rifampicin-resistant tuberculosis, Acute kidney injury, Drug-induced liver injury
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflict of interest.
260